Skip to main content
Top
Published in: Journal of Clinical Immunology 8/2019

01-11-2019 | Original Article

Survey of Infection Control Precautions for Patients with Severe Combined Immune Deficiency

Authors: Brieanne A. Dergousoff, Joseph V. Vayalumkal, Nicola A. M. Wright

Published in: Journal of Clinical Immunology | Issue 8/2019

Login to get access

Abstract

Severe combined immune deficiency (SCID) is caused by an array of genetic disorders resulting in a diminished adaptive immune system due to impaired T lymphocytes. In these patients, active infection at the time of hematopoietic transplantation has been shown to increase morbidity and mortality. To prevent transmission of infections in SCID patients, standardized infection control precautions should be implemented. An online survey regarding SCID-specific protocols was distributed through several immunodeficiency organizations. Seventy-three responses were obtained, with the majority (55%) of responses from the USA, 15% from Canada, and the remainder from 12 other countries. Only 50% of respondents had a SCID-specific infection control protocol at their center, and while a majority of these centers had training for physicians, a small minority had training for other healthcare workers such as nursing and housekeeping staff. Significant variability of infection control practices, such as in-patient precautions, required personal protective equipment (PPE), diet restrictions, visitor precautions and discharge criteria, was found between different treatment centers. There is a paucity of evidence-based data regarding the safest environment to prevent infection in SCID patients. Institutional protocols may have significant impact on infection risk, survival, family well-being, child development and cost of care. From these results, it is evident that further multi-center research is required to determine the safest and healthiest environment for these children, so that evidence-based infection control protocols for patients with SCID can be developed.
Appendix
Available only for authorised users
Literature
4.
go back to reference CDC. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep. 2000;49:1–125. CDC. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep. 2000;49:1–125.
7.
go back to reference Magauran CE, Salgado CD. Challenges and advances in infection control of hematopoietic stem cell transplant recipients. Infect Disord Drug Targets. 2011;11:18–26.CrossRef Magauran CE, Salgado CD. Challenges and advances in infection control of hematopoietic stem cell transplant recipients. Infect Disord Drug Targets. 2011;11:18–26.CrossRef
10.
go back to reference Wujcik D. Infection control in oncology patients. Nurs Clin N Am. 1993;28:639–50. Wujcik D. Infection control in oncology patients. Nurs Clin N Am. 1993;28:639–50.
11.
go back to reference Antoine C, Muller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet. 2003;361:553–60.CrossRef Antoine C, Muller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet. 2003;361:553–60.CrossRef
12.
go back to reference Buckley RH, Shiff SE, Shiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340:508–16.CrossRef Buckley RH, Shiff SE, Shiff RI, et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med. 1999;340:508–16.CrossRef
17.
18.
go back to reference Hicheri Y, Einsele H, Martino R, Cesaro S, Ljungman P, Cordonnier C. Environmental prevention of infection in stem cell transplant recipients: a survey of the infectious diseases working Party of the European Group for blood and marrow transplantation. Transpl Infect Dis. 2013;15:251–8. https://doi.org/10.1111/tid.12064.CrossRefPubMed Hicheri Y, Einsele H, Martino R, Cesaro S, Ljungman P, Cordonnier C. Environmental prevention of infection in stem cell transplant recipients: a survey of the infectious diseases working Party of the European Group for blood and marrow transplantation. Transpl Infect Dis. 2013;15:251–8. https://​doi.​org/​10.​1111/​tid.​12064.CrossRefPubMed
29.
go back to reference van Tiel FH, Harbers MM, Kessels AG, Schouten HC. Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenias. Ann Oncol. 2005;16:195–205.CrossRef van Tiel FH, Harbers MM, Kessels AG, Schouten HC. Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenias. Ann Oncol. 2005;16:195–205.CrossRef
32.
go back to reference Salgado CD, Giannetta ET, Hayden FG, Farr BM. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol. 2004;25:923–8.CrossRef Salgado CD, Giannetta ET, Hayden FG, Farr BM. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol. 2004;25:923–8.CrossRef
33.
go back to reference Gaspar HB, Qasim W, Davies EG, Rao K, Amrolia PJ, Veys P. How I treat severe combined immunodeficiency. Blood. 2013;122:3749–58.CrossRef Gaspar HB, Qasim W, Davies EG, Rao K, Amrolia PJ, Veys P. How I treat severe combined immunodeficiency. Blood. 2013;122:3749–58.CrossRef
Metadata
Title
Survey of Infection Control Precautions for Patients with Severe Combined Immune Deficiency
Authors
Brieanne A. Dergousoff
Joseph V. Vayalumkal
Nicola A. M. Wright
Publication date
01-11-2019
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 8/2019
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-019-00671-y

Other articles of this Issue 8/2019

Journal of Clinical Immunology 8/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.